Open access
90
Views
7
CrossRef citations to date
0
Altmetric
Expert Opinion
Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy
Michael Gold1 Allon Therapeutics Inc, Vancouver, BC, Canada
, Stefan Lorenzl2 Interdisciplinary Center for Palliative Medicine, Munich University Hospital Klinikum Grosshadern, Munich, Germany
, Alistair J Stewart1 Allon Therapeutics Inc, Vancouver, BC, Canada
, Bruce H Morimoto1 Allon Therapeutics Inc, Vancouver, BC, Canada
, David R Williams3 Van Cleef/Roet Centre for Nervous Diseases, Monash University, Melbourne, Australia
& Illana Gozes1 Allon Therapeutics Inc, Vancouver, BC, Canada;4 The Dr Diana and Zelman Elton (Elbaum) Laboratory for Molecular Neuroendocrinology, The Lily and Avraham Gildor Chair for the Investigation of Growth Factors, The Adams Super Center for Brain Studies, and the Department of Human Molecular Genetics and Biochemistry, School of Neuroscience, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelCorrespondence[email protected]
Pages 85-93
|
Published online: 09 Feb 2012
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.